Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

N-of-1 trials can be aggregated to generate group mean treatment effects: a systematic review and meta-analysis.

Punja S, Xu D, Schmid CH, Hartling L, Urichuk L, Nikles CJ, Vohra S.

J Clin Epidemiol. 2016 Aug;76:65-75. doi: 10.1016/j.jclinepi.2016.03.026. Epub 2016 Apr 20. Review.

PMID:
27107878
2.

Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

Storebø OJ, Ramstad E, Krogh HB, Nilausen TD, Skoog M, Holmskov M, Rosendal S, Groth C, Magnusson FL, Moreira-Maia CR, Gillies D, Buch Rasmussen K, Gauci D, Zwi M, Kirubakaran R, Forsbøl B, Simonsen E, Gluud C.

Cochrane Database Syst Rev. 2015 Nov 25;(11):CD009885. doi: 10.1002/14651858.CD009885.pub2. Review.

PMID:
26599576
3.

To meta-analyze or not to meta-analyze? A combined meta-analysis of N-of-1 trial data with RCT data on amphetamines and methylphenidate for pediatric ADHD.

Punja S, Schmid CH, Hartling L, Urichuk L, Nikles CJ, Vohra S.

J Clin Epidemiol. 2016 Aug;76:76-81. doi: 10.1016/j.jclinepi.2016.03.021. Epub 2016 Apr 7. Review.

PMID:
27060386
4.

Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.

Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK.

Clin Ther. 2007 Jun;29(6):1168-77.

PMID:
17692731
5.
6.

Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents.

Punja S, Shamseer L, Hartling L, Urichuk L, Vandermeer B, Nikles J, Vohra S.

Cochrane Database Syst Rev. 2016 Feb 4;2:CD009996. doi: 10.1002/14651858.CD009996.pub2. Review.

PMID:
26844979
7.

Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine.

Hennissen L, Bakker MJ, Banaschewski T, Carucci S, Coghill D, Danckaerts M, Dittmann RW, Hollis C, Kovshoff H, McCarthy S, Nagy P, Sonuga-Barke E, Wong IC, Zuddas A, Rosenthal E, Buitelaar JK; ADDUCE consortium.

CNS Drugs. 2017 Mar;31(3):199-215. doi: 10.1007/s40263-017-0410-7. Review.

8.

Risk of Irritability With Psychostimulant Treatment in Children With ADHD: A Meta-Analysis.

Stuckelman ZD, Mulqueen JM, Ferracioli-Oda E, Cohen SC, Coughlin CG, Leckman JF, Bloch MH.

J Clin Psychiatry. 2017 Jun;78(6):e648-e655. doi: 10.4088/JCP.15r10601.

PMID:
28682529
9.

Effect of psychostimulants on brain structure and function in ADHD: a qualitative literature review of magnetic resonance imaging-based neuroimaging studies.

Spencer TJ, Brown A, Seidman LJ, Valera EM, Makris N, Lomedico A, Faraone SV, Biederman J.

J Clin Psychiatry. 2013 Sep;74(9):902-17. doi: 10.4088/JCP.12r08287. Review.

11.

Systematic evidence synthesis of treatments for ADHD in children and adolescents: indirect treatment comparisons of lisdexamfetamine with methylphenidate and atomoxetine.

Roskell NS, Setyawan J, Zimovetz EA, Hodgkins P.

Curr Med Res Opin. 2014 Aug;30(8):1673-85. doi: 10.1185/03007995.2014.904772. Epub 2014 Apr 15. Review.

PMID:
24627974
12.
13.

Effects of stimulants and atomoxetine on emotional lability in adults: A systematic review and meta-analysis.

Moukhtarian TR, Cooper RE, Vassos E, Moran P, Asherson P.

Eur Psychiatry. 2017 Jul;44:198-207. doi: 10.1016/j.eurpsy.2017.05.021. Epub 2017 May 25. Review.

PMID:
28646732
14.

Cardiac safety of methylphenidate versus amphetamine salts in the treatment of ADHD.

Winterstein AG, Gerhard T, Shuster J, Saidi A.

Pediatrics. 2009 Jul;124(1):e75-80. doi: 10.1542/peds.2008-3138.

15.

Amfetamine for attention deficit hyperactivity disorder in people with intellectual disabilities.

Thomson A, Maltezos S, Paliokosta E, Xenitidis K.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD007009. doi: 10.1002/14651858.CD007009.pub2. Review.

PMID:
19160313
16.
17.
18.

Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder: a meta-regression analysis.

Castells X, Ramos-Quiroga JA, Rigau D, Bosch R, Nogueira M, Vidal X, Casas M.

CNS Drugs. 2011 Feb;25(2):157-69. doi: 10.2165/11539440-000000000-00000.

PMID:
21254791
19.

Randomized clinical study of a histamine H3 receptor antagonist for the treatment of adults with attention-deficit hyperactivity disorder.

Weisler RH, Pandina GJ, Daly EJ, Cooper K, Gassmann-Mayer C; 31001074-ATT2001 Study Investigators.

CNS Drugs. 2012 May 1;26(5):421-34. doi: 10.2165/11631990-000000000-00000.

PMID:
22519922
20.

Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder.

Faraone SV, Spencer T, Aleardi M, Pagano C, Biederman J.

J Clin Psychopharmacol. 2004 Feb;24(1):24-9.

PMID:
14709943

Supplemental Content

Support Center